Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_assertion type Assertion NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_head.
- NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_assertion description "[Of the informative human hepatocellular carcinoma samples 47.06% (8 of 17) demonstrated a gain of imprinting of IGF2, and 21.74% (5 of 23) of the informative HCC samples demonstrated a loss of imprinting of H19.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_provenance.
- NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_assertion evidence source_evidence_literature NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_provenance.
- NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_assertion SIO_000772 18358696 NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_provenance.
- NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_assertion wasDerivedFrom lhgdn-20090331 NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_provenance.
- NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_assertion wasGeneratedBy ECO_0000203 NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_provenance.